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Abstract
Background: Cell banking of initial outgrowths from newly derived human embryonic stem
cells (hESCs) requires an efficient freezing method. Vitrification is used for the preservation of
gametes and early embryos in assisted reproduction techniques (ART). Moreover, vitrification
was applied for cryopreservation of hESCs using open pulled straws.
Objective: To derive and characterize new hESC lines and then use Cryotech and Cryowin tools
for their vitrification.
Materials and Methods: Human ESC lines were generated in a microdrop culture system using
mouse embryonic fibroblasts (MEFs) as the feeder layer; this was later scaled up using both
MEFs and Yazd human foreskin fibroblasts batch 8 (YhFF#8). To bank the cell lines, master cell
banks of 100 Cryotech and Cryowin tools were produced for each individual cell line using the
vitrification method; flasks of hESC lines were also cryopreserved using a conventional slow-
freezing method.
Results: The pluripotency of cell lines was assessed by their expression of pluripotency-
associated genes (OCT4/POU5F1, NANOG, and SOX2) and markers such as SSEA4, TRA-
1-60, and TRA-2-49. Their in vitro capacity to differentiate into germ layers and germ cells
using embryoid body (EB) formation and monolayer culture was assessed by screening the
expression of differentiation-associated genes. The chromosomal constitution of each hESC
line was assessed by G-banding karyotyping.
Conclusion:Cryotech andCryowin tools used to vitrify new hESCs at an early stage of derivation
is an efficient method of preserving hESCs.
Key words: Derivation, Human embryonic stem cells, Human foreskin fibroblast,
Microdrop, Vitrification.
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1. Introduction
Stem cells have been known for a long time,
but the generation of embryonic stem cells
(ESCs) altered the concept of what constitutes
a stem cell (1). Using immunosurgery (2), mouse
ESCs (mESCs) were first derived in 1981 (3,
4). Later, other groups made unsuccessful
attempts to generate human ESCs (hESCs) (5),
followed by generation of ESCs in primates (6, 7),
and eventually, in 1998, hESCs were derived
(8). This coincided with the advent of their
putative counterpart, human embryonic germ
cells (hEGCs) (9). Typical hESC morphology is an
initial characteristic that helps in the derivation
process. The morphology of hESCs is very
similar to pluripotent embryonal carcinoma cells
(ECCs), with a high ratio of nuclei to cytoplasm,
pale nuclei, and prominent nucleoli (10). Four
major factors play a critical role in the hESC
derivation process. (a) The source and stage
of pre-implantation embryos from cleavage (11)
to blastocyst (8). Recently, it was shown that
embryos obtained following in vitro twinning
can be used for the generation of hESC-like
cells; however, attempts to establish a cell
line have yet to succeed (12). (b) The method
of derivation used, such as inner cell mass
(ICM) isolation using immunosurgery (13), laser-
assisted ICM biopsy (14), blastomere biopsy
(15), mechanical isolation of the ICM (16), and
whole zona-free blastocyst culture (13, 17). (c)
Different sources of feeder layer, from mouse
embryonic fibroblasts (MEFs) (13) to human
derived feeders, such as human foreskin
fibroblasts (HFFs) (12, 18), human fetal gonadal
fibroblasts (HFGFs) (13), human endometrial-
derived fibroblasts (19), and human cumulus cells
(hCCs) (20). (d) The scale of cell culture used,
i.e., either an open (13, 17) or a microdrop system
(13).
Following their initial derivation, hESCs must be
cryopreserved and expanded for further charac-
terization of specific gene and marker expression
to assess their undifferentiated status (13). In addi-
tion, their capacity to differentiate into the three
germ layers (ectoderm, mesoderm, and endoderm)
and germ cells, to demonstrate their pluripotency,
should be evaluated, either by in vitro embryoid
body (EB) formation or by in vivo teratocarci-
noma formation, to investigate further differentia-
tion potential (21). The chromosome content of the
cell line is another issue that can be evaluated byG-
binding or the CGH-array method (22). One of the
challenges in banking any cell type is the method
of freezing used. The use of an ideal method
for cryopreservation can improve the survival rate
and proliferative capacity of post-thawed hESCs
(23). Studies have demonstrated that fewer than
5% of hESCs survived an equilibrium slow-freezing
procedure using 10% dimethylsulphoxide (DMSO)
in fetal calf serum; in contrast, high viability among
hESCs was reported when using a vitrification
procedure for the cell lines using an “open pulled-
straw” method with a small volume of cells (13).
Vitrification is a state-of-the-art method used for
the freezing of a small number of cells, including
gametes and embryos, and is used for the cryop-
reservation of hESCs using an open pulled-straw
method (13). Vitrification is also a good choice of
method to use shortly after the derivation of hESCs
that are in urgent need of cell line preservation (23).
Here, we report the vitrification of new out-
growths to save newly derived hESC lines (Yazd1-
3) using Cryotech and Cryowin tools. Whole, zona-
free blastocysts were cultured on an MEF feeder
layer in microdrop culture. The purpose of this
studywas first to derive and characterize newhESC
lines and then using Cryotech and Cryowin tools
for their vitrification (although this method was not
compared with a conventional open pulled-straws
method).
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2. Materials and Methods
Chemicals were purchased from Sigma Aldrich
(Poole, UK). Culture media and supplements were
purchased from Invitrogen and Gibco (UK), unless
otherwise stated.
2.1. Embryo culture
The vitrified donated embryos (n = 10) were
warmed as described elsewhere (24) and cultured
in a microdrop system with G series medium
(version III; Vitrolife) plus 5% human serum albumin
(Vitrolife) till getting to the blastocyst stage. The
fresh donated embryos were cultured in the same
culturemedium for in vitro blastocyst development.
2.2. Preparation of the microdrops of
feeders
MEFswere derived fromNavalMedical Research
Institute (NMRI) mouse embryos according to ethi-
cal guidelines relating to animals and cultured as
described elsewhere (25). Briefly, 13 days after
the appearance of the vaginal plug, fetuses were
recovered from the uterus and their heads, spinal
cords, and livers were removed. Following enzy-
matic and mechanical treatment, the resulting cell
suspension was transferred to a T25 tissue cul-
ture flask containing Dulbecco’s Modified Eagle’s
Medium (DMEM), 10% fetal bovine serum (FBS),
and antibiotics, then incubated at 37°C in 5%
CO2 in air. Yazd HFFs batch 8 (YhFF#8) were
isolated and expanded from neonatal human fore-
skin tissues after obtaining fully informed written
consent, according to the guidelines of the Shahid
Sadoughi University of Medical Sciences Ethical
Committee (ethics committee reference number:
IR.SSU.REC.1394.103; Aflatoonian et al., unpub-
lished data). MEFs and YhFFs#8 were mitotically
inactivated using Mitomycin-C (by adding 2 mg
Mitomycin-C to 200 ml DMEM/10% FBS) for 2
and 4 hrs, respectively. After washing three times
with Dulbecco’s phosphate buffered saline (D-
PBS), cells were detached using 1 x trypsin/EDTA,
centrifuged at 1000 rpm for 5 minutes, and then
re-plated in 50 µl drops onto dishes (Falcon, USA)
at a concentration of 3,500 cells per 50 µl and
covered with mineral oil (Irvine Scientific, USA). The
following day the microdrop medium of feeders
was replaced with KOSR/HES medium (contain-
ing KnockOut DMEM, KnockOut Serum Replace-
ment, L-glutamine/β mercaptoethanol, bFGF, non-
essential amino acids, and antibiotics) and left for
2 hrs for conditioning prior to use. Each dish was
plated with seven microdrops of feeder layer.
2.3. Generation of Yazd hESC lines
(Yazd1-3) using the microdrop method
To obtain intact zona-free blastocysts, and
based on the grade of each individual blastocyst,
embryos were either cultured to fully hatched
blastocyst stage or were treated with pronase (2
mg/ml; Calbiochem, USA) to lyse the zona pellu-
cida. The intact zona-free blastocysts were plated
onto the microdrops of MEF feeders. Yazd1 cells
were initially generated using VitroHES culture
medium (ready-to-use from Vitrolife), Yazd2 cells
were derived and expanded in KOSR/HESmedium,
while for Yazd3 cells were, the blastocysts were
initially cultured in DMEM/10% FBS overnight, and
the following day the medium was exchanged
for KOSR/HES medium. Small modifications to
the culture conditions for the derivation of each
individual Yazd hESC line (Yazd1-3) are shown in
Table I.
All three cell lines were derived using intact
embryo co-culture on a microdrop of MEF feeders.
All lines were later expanded on both MEFs (ini-
tially) and Yazd HFFs (YhFF#8). Yazd1 cells were
generated from a fresh embryo, which was cultured
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to the blastocyst stage (grade 3CB) in VitroHES
medium. Yazd2 cells were derived from a frozen-
warmed embryo, which was allowed to develop
to the early cavity stage (grade 1) on KOSR/HES
medium. Yazd3 cells were generated from an
embryo which lost its zona during the freezing and
thawing process and was allowed to develop to
the blastocyst stage (grade 2). All cell lines were
expanded using KOSR/HES medium. Yazd1 and
Yazd2 hESC lines contained normal karyotypes
(46, XX and 46, XY, respectively); however, the
Yazd3 karyotype was initially a triploid 69, XXY.
2.4. Expansion and EB formation of
Yazd hESC lines (Yazd1-3)
To establish the Yazd1-3 hESC lines following
initial hESC outgrowth formation, the cells were
mechanically passaged using a mouth pipette and
pulled Pasteur pipettes. To detach the colonies,
they were first treated with collagenase type IV
(1 mg/ml) at 37°C in 5% CO2 in air for 8-10 min.
A one drop-one colony method was used for the
expansion of the Yazd hESC lines (Figure 1A and
B). Following enzymatic treatment, themediumwas
replaced with KOSR/HES medium, colonies were
cut into smaller pieces (Figure 1C and D) gently
by pulled glass Pasteur pipette were plated either
onto the new feeders (in different scales) with
KOSR/HESmedium (Figure 1A and F). Both YhFF#8
(Figure 1G) and MEFs (Figure 1H) were used for the
expansion of Yazd1-3 cell lines. To prevent hESCs
differentiating, daily feeding with fresh medium
was performed by replacing half the medium.
Occasionally, Yazd3 colonies appeared morpho-
logically different from the normal flattened shape,
becoming rounder and forming clusters, possibly
due to the development of progenitor cells. To
prevent further differentiation, these colonies were
treated with dispase (10 mg/ml in KOSR/HES).
Briefly, colonies were washed twice with pre-
warmed PBS and then cut into small pieces. The
PBS was replaced with dispase solution following
incubation for 2 minutes at 37°C. The small pieces
of colonies were washed in three pre-warmed
PBS drops, and then plated onto new micro-
drops containing feeders, each drop one colony.
For the feeder-free culture of colonies, Matrigel
was applied together with KOSR/HES-conditioned
medium (Figure 1I). The EB formation procedure
(Figure 1J) was similar to passaging, in which small
pieces of colonies were plated in non-adherent
culture dishes with EB medium (KOSR/HES without
bFGF).
2.5. Cryopreservation and thawing of
Yazd hESC lines (Yazd1-3)
Two different methods were applied for freezing
the Yazd1-3 hESC lines, according to the scale
of the culture. Colonies within the microdrops
for master cell-banking were cryopreserved using
Cryotech and Cryowin tools (Cryotec, Cryotech,
Japan and Cryowin, TechWin, Iran; Figure 1E) for
the vitrification method (13). For larger scale cul-
tures, such as central well dishes or tissue culture
flasks (Figure 1F), at later passages colonies were
frozen using a slow-freezing solution consisting of
10% DMSO in FBS. In summary, for vitrification,
small pieces (larger than pieces usually used for
passaging) of hESC colonies were scraped off and
placed into a small drop of KOSR/HES medium.
Then, colonies were transferred into homemade
vitrification solutions 1 and 2 (VS1 and VS2) con-
taining ethylene glycol and DMSO, first at 10%,
then at 20%, respectively, in basal medium (DMEM,
20% FBS, and non-essential amino acids). Small
colonies were drawn onto the Cryotech and Cry-
owin tools, plunged into liquid nitrogen, and then
transferred to long cryovials, which were sealed
with a cap located in the cryocane and placed in
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a liquid nitrogen storage container. For thawing,
a Cryotech or Cryowin was taken from the liquid
nitrogen container tank and then placed into a
drop of KOSR/HESmedium. The cells were washed
five times by transferring them through more drops
before being placed onto microdrops containing
feeders in KOSR/HES medium and incubated at
37°C at 5% CO2 in air.
2.6. Immunofluorescent localization
(IF) of pluripotency markers
The identification of pluripotency-associated cell
markers was carried out using IF localization, as
previously described (26). In summary, Yazd1-3
hESC colonies were washed with PBS containing
1% FBS before being fixed in cooled methanol
(−20°C) for 15 minutes. Samples were washed
twice for 5 min in D-PBS containing 1% FBS
and then incubated overnight at 4°C with primary
antibodies (SSEA4, TRA-1-60, and TRA-2-49; kindly
gifted by Professor Peter W. Andrews from the
Centre for Stem Cell Biology, Sheffield University,
UK) diluted (1:10) in D-PBS. Samples were then
washed twice in PBS and incubated with appro-
priate secondary antibodies for 1 hr at 37°C (see
Table II). Preparations were covered with mounting
medium (Vectashield, Vector Laboratories, USA)
and examined microscopically using fluorescence
with appropriate excitation optics on an inverted
microscope (Olympus IX-71). Experiments were per-
formed in triplicate.
2.7. RNA isolation, cDNA production,
and reverse transcription PCR
Undifferentiated colonies and spontaneously
differentiated EBs following different culture peri-
ods (4, 7, and 14 days) and differentiated colonies
in the monolayer culture system (after 7 days) were
collected. The resulting pellets were suspended
in 1 mL TRI reagent (Sigma) and total RNA was
extracted according to the standard protocol sup-
plied by the manufacturer. Total RNA was treated
with DNase I (RNase-free Kit; Fermentas, Ger-
many) to remove genomic DNA. First-strand cDNA
synthesis was performed using the Superscript
II reverse transcriptase system (Fermentas, Ger-
many). PCR was performed using the prepared
cDNA and primers for different genes (Table III) by
Platinum Blue PCR Super Mix (Invitrogen, UK) in
triplicate. PCR cycling conditions were as follows:
5min at 95°C for initial denaturation, followed by 40
cycles of 45 sec at 95°C, 45 sec at 59°C-65°C (see
Table III), and 45 sec at 72°C.
2.8. Karyotype analysis of Yazd hESC
lines (Yazd1-3)
To investigate the chromosomal content of
Yazd1-3 hESC lines, the karyotype of ten cells in
metaphase of each Yazd cell line was determined
by a standard G-banding procedure. Briefly, cells
were cultured in flasks without feeder for 5 to 6
days to formmesenchymal-like cells (27). Following
treatment with colchicine (10 µg/ml), harvested
Yazd hESC-derived cells were stained using a
standard G-banding technique. G-bandings were
analyzed under light microscopy (Axiophot, Ziess,
Germany) using applied spectral imaging software.
2.9. In vitro differentiation of Yazd
hESC lines (Yazd1-3)
In vitro differentiation of Yazd1-3 hESC lines was
performed as previously described (13), using EB
formation and gene expression profile assessment
after 4, 7, and 14 days for mesoderm, endoderm,
ectoderm, and germ-cell development. The same
was done for spontaneously differentiation in the
monolayer culture with DMEM/10% FBS (after 7
days).
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Yazd1 Fresh 3CB full blastocyst + MEF MEF/ YhFF#8 VitroHES (Vitrolife) 46, XX
Yazd2 Frozen 1 early blastocyst + MEF MEF/ YhFF#8 KOSR/HES 46, XY
Yazd3 Frozen 2 blastocyst - MEF MEF/ YhFF#8 DMEM/10% FBS 69, XXY
Table II. List of primary and secondary antibodies used for immunofluorescent (IF) localization
Primary antibody Secondary antibody














Table III. List of primers used for RT-PCR, showing specifications
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Figure 1. Culture of Yazd1-3 hESC lines at different scales on MEFs and YhFFs#8. The one drop-one colony method was used for
expansion of the Yazd hESC lines (A, B). For the passage procedure, following enzymatic treatment, themediumwas replacedwith
KOSR/HES medium and colonies were cut into smaller pieces (C, D). Cryotech and Cryowin tools were used for the vitrification
of Yazd hESCs from the initial derivation steps. In this figure, each drop contains two relatively large pieces of hESC colonies
(E). Yazd1-3 hESC lines were expanded using larger scale culture methods, such as central well dishes and tissue culture flasks
(F). Both MEFs (A, B, and H) and YhFFs#8 (F, G) were used for the expansion of Yazd1-3 hESC lines. Matrigel was applied with
KOSR/HES-conditioned medium for the feeder-free culture of colonies (I). The EB formation procedure was similar to passaging,
in which small pieces of colonies were plated in non-adherent culture dishes with EB medium (J).
2.10. Ethical considerations
Sixteen fresh (n = 6) and frozen (n = 10) super-
numerary embryos were donated for research
by infertile couples after they had provided
full, written, informed consent according to the
Shahid Sadoughi University of Medical Sciences
Ethical Committee (ethics committee reference
number: IR.SSU.REC.1394.104). For research pur-
poses, all embryos were coded to ensure patient
anonymity.
3. Results
3.1. Generation of Yazd1-3 hESC lines
In the current study, sixteen fresh (n = 6)
and frozen (n = 10) donated surplus human
embryos were used to generate Yazd1-3 hESC
lines using a microdrop culture system (13)
(Figure 1A and B) and MEFs as feeder layer
cells. The pre-implantation human embryos
(Figure 2A and 3A) were used as described
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above following pronase treatment (for Yazd1
and Yazd2) in a 50 μl microdrop co-culture
system (Figure 1A and B). The Yazd1 cell line
was produced from a fresh 3CB full blastocyst
donated for stem cell research (Figure 2A),
which was plated onto a microdrop of MEFs
(Figure 2B). After two days, the outgrowth
of cells was observed (Figure 2C). Following
eight passages, colonies with a typical hESC
morphology were obtained (Figure 2D). The
Yazd1 cell line was derived and initially expanded
using VitroHES (Vitrolife) culture medium. For the
generation of the Yazd2 cell line, a frozen-
warmed embryo, which had been donated
for stem cell research was developed to
the early blastocyst stage (grade 1) in vitro,
the zona pellucida was lysed as described
above, and plated onto a microdrop of MEFs
(Figure 3A) in KOSR/HES medium. The first
outgrowths after two and three days were
as shown in Figure 3B and C, respectively.
As indicated in Figure 3C, a population of
cells were overgrown, resembling putative
hEGC clusters (28), which were distinguished
from these areas after several passages of
hESC colonies (Figure 3D). To derive Yazd3
cells, a frozen embryo donated for stem
cell research was thawed. During thawing
the zona pellucida was destroyed and the
zona-free embryo was allowed to develop
to blastocyst stage (grade 2) in vitro, plated
onto a microdrop of MEFs (Figure 4A), and
then incubated overnight in DMEM/10%
FBS. On the following day attachment of
the embryo onto the feeder layer and the
medium was replaced with KOSR/HES. The
first outgrowths after two and five days were
as shown in Figure 4B and C, respectively.
Following passaging, as previously described
(13) and explained above, for Yazd2 cells a
compact area (Figure 4C) was distinguished
from other parts of the colony from which, in
later passages, typical hESC colonies were
generated (Figure 4D). Summary information
of modifications to the techniques used for
derivation of Yazd1-3 hESC lines is shown in
Table I.
3.2. Establishment of Yazd1-3 hESC
lines
All Yazd cell lines (1-3) were initially derived
and expanded on MEFs (Figure 1 A, B, and H).
Later, YhFFs#8 (Figure 1F and G) and Matrigel
(Figure 1I) were applied to maintain undifferen-
tiated Yazd hESCs in culture. Half of the KOS-
R/HES medium was replaced with fresh medium
each day. Non-adherent petri-dishes with EB
medium were used to produce EBs (Figure 1J)
to induce spontaneous differentiation in vitro
(13).
Yazd1 hESCs (passage number 7+5+10) showed
positive expression of pluripotency associated
markers, SSEA4 (Figure 2E-G), TRA-1-60 (Figure
2H-J), and TRA-2-49 (Figure 2K-M), as assessed
using an IF technique. Undifferentiated Yazd1
cells expressed the pluripotency genes NANOG,
SOX2, and OCT4/POU5F1 (Figure 2N) determined
by RT-PCR and contained normal 46, XX kary-
otypes (Figure 2O). Yazd2 hESCs (passage number
8+38+10) displayed expression of pluripotency-
associated markers such as SSEA4 (Figure 3E-
G), TRA-1-60 (Figure 3H-J), and TRA-2-49 (Figure
3K-M) and genes such as NANOG, SOX2, and
OCT4/POU5F1 (Figure 3N), as assessed by IF
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and RT-PCR, respectively. The initial karyotype of
Yazd2 hESCs was normal, 46, XY, as revealed by
a G-binding procedure (Figure 3O). The undiffer-
entiated Yazd3 hESC colonies (passage number
68) were characterized by SSEA4 (Figure 4E-G),
TRA-1-60 (Figure 4H-J), and TRA-2-49 (Figure 4K-M)
using IF, and NANOG, SOX2, and OCT4/POU5F1
using RT-PCR (Figure 4N). Yazd3 was an abnor-
mal hESC line with a karyotype of 69, XXY in
its early passages (passage number 8; Figure
4O).
3.3. In vitro differentiation of Yazd1-3
hESC lines
The pluripotent differentiation capacity of the
first three Yazd hESC lines (Yazd1-3) was proven
in vitro using different EB formations (Figure 5
and Figure 6) and monolayer cultures (Figure 7),
with assessment of the expression of specific
genes for the three germ layers and germ cells.
Differentiated cells expressed specific genes of
the three embryonic germ layers (SLC2A1, PAX6,
TUBB3, DES, and TBXT) and germ cells (VASA and
DAZL).
Figure 2. Derivation and characterization of the Yazd1 hESC line. The Yazd1 cells were produced from a donated, fresh, grade
3CB full blastocyst (A). The blastocyst stage embryo was plated onto a microdrop of MEFs (B). The first outgrowth of cells was
observed after two days (C); following eight passages, colonies with typical hESC morphology (D) were visible. The expression of
pluripotencymarkers SSEA4 (E-G), TRA-1-60 (H-J), and TRA-2-49 (K-M) was assessed by IF staining. The expression of pluripotency
genes NANOG, SOX2, and OCT4/POU5F1 (N) was evaluated using RT-PCR of undifferentiated Yazd1 hESCs. A normal, 46, XX
karyotype for the Yazd1 hESC line (O) was detected by G-binding. The latest passage of Yazd1 for characterization was passage
7+5+10.
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Figure 3. Derivation and characterization of the Yazd2 hESC line. The Yazd2 cells were generated from an early blastocyst stage
(grade 1) embryo plated onto a microdrop of MEFs (A). The first outgrowth after two (B) and three days (C). After several passages,
hESC colonies were distinguished (D). The positive expression of the pluripotency markers SSEA4 (E-G), TRA-1-60 (H-J), and TRA-
2-49 (K-M) was tested using IF. RT-PCR data showed expression of the pluripotency genes, NANOG, SOX2, and OCT4/POU5F1
(N) in undifferentiated cells. A normal 46, XY karyotype for the Yazd2 hESC line (O) was detected using G-binding. Yazd2 is still in
culture with the latest passage number being P8+38+58. The characterization of Yazd2 was performed after P8+38+10.
Figure 4. Derivation and characterization of the Yazd3 hESC line. The Yazd3 cells were derived from a zona-free, grade 2,
blastocyst stage embryo, which was plated onto a microdrop of MEFs (A). The first outgrowth after two (B) and five days (C). hESC
colonies of Yazd3 in later passages (D). The positive expression of the pluripotency markers SSEA4 (E-G), TRA-1-60 (H-J), and TRA-
2-49 (K-M) was tested using IF. RT-PCR data showed the expression of the pluripotency genes NANOG, SOX2, andOCT4/POU5F1
(N). An abnormal, triploid 69, XXY karyotype for the Yazd3 hESC line (O) was shown using G-binding. The Yazd3 cells were frozen
down after passage number 169. The karyotype of Yazd3 was assessed during passages 4, 32, and 89. Characterization of Yazd3
was done after passage 68.
Page 900 https://doi.org/10.18502/ijrm.v17i12.5808
International Journal of Reproductive BioMedicine Cell banking of newly derived Yazd hESC lines using vitrification
Figure 5. RT-PCR for the three embryonic germ-layer markers. Differentiation of Yazd1-3 hESC lines into the three embryonic germ
layers (ectoderm: PAX6, TUBB3; mesoderm: DES, TBXT; endoderm: SLC2A1) using EB formation after 4, 7, and 14 days.
Figure 6. RT-PCR for germ-cell markers. Differentiation of Yazd1-3 hESC lines to germ cells (VASA and DAZL) using EB formation
after 4, 7, and 14 days.
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Figure 7. RT-PCR for three embryonic germ-layer/germ-cell markers. Differentiation of Yazd1-3 hESC lines to the three embryonic
germ layers (ectoderm: PAX6, TUBB3; mesoderm: DES, TBXT; endoderm: SLC2A1) and germ cells (VASA and DAZL) using
monolayer culture after 7 days.
4. Discussion
This study reports the derivation of Yazd1-3
hESC lines, initially using an MEF feeder layer
in a microdrop culture system, and the banking
of these cell lines using Cryotech and Cryowin
tools for vitrification, which has started since 2008.
Later Yazd hESCswere expanded on YhFF#8while
establishment and characterization.
Following the generation of Shef lines using
the microdrop culture system, we have applied
this method for the derivation of new Yazd hESC
lines (13). In recent studies, the efficiency of hESC
derivation was reported to be more than 50%
(29). In this study, however, three new hESC lines
(Yazd1-3) were generated from sixteen fresh and
frozen embryos, representing a success rate of
18.75%. This difference could be due either to
the source of the embryos or the culture con-
ditions, which in our case involved conventional
KOSR/HES medium with MEFs as a feeder layer.
The success rate for hESC generation from fresh
embryos in this study was about 16.66%, whereas
it was 20% for hESC lines derived from frozen
embryos. As far as we know, this is the first
report to describe the vitrification of hESCs using
Cryotech and Cryowin tools; however, no com-
parisons were made between the efficiency of
this method with the conventional open pulled
straws method. This new method is applicable
for the preservation of early outgrowths in early
passages of pluripotent stem cells, and in our
experience: hESCs. The new Yazd1-3 hESC lines
were characterized by specific pluripotency mark-
ers, such as SSEA-4, TRA-1-60, and TRA-2-49,
and pluripotency genes, including NANOG, SOX2,
and OCT4/POU5F1. Furthermore, the differentia-
tion potential of the cell lines in EB formation and
monolayer culture was determined using RT-PCR
for the three embryonic germ layers and germ-cell-
specific genes.
The use of a microdrop culture system was
first reported in 1994 for the culturing of bovine
ESC (30). In an open culture system, secreted
growth factors may be lost or diluted, whereas
it has been demonstrated that a combination of
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a co-culture and a microdrop system had the
highest rates of blastocyst formation and hatch-
ing in comparison with an open co-culture sys-
tem (31). Wakayama and colleagues (32) derived
mESC lines using an efficient micro-scale method.
Single blastomeres were co-cultured with MEFs
in individual wells of 96-well plates. Follow-
ing that, Aflatoonian and co-workers generated
hESC lines using a microdrop culture system
(13).
In assisted reproductive techniques (ART), a
laser is commonly used to assist with different
processes, such as assisted hatching (33) and
blastomere and trophectoderm (TE) biopsies (34).
In addition, laser-assisted technology has been
used for ICM biopsies in mice (35, 36) and humans
(14, 22, 37, 38, 39). In the present study, no
ICM isolation methods, such as immunosurgery
and laser-assisted biopsy, were used. The Yazd1-2
hESC lines were derived from blastocyst and early
cavity embryos respectively, which were extruded
from the zona pellucida by pronase treatment. It
should be noted; however, that pronase is derived
from bacteria and is therefore not suitable for the
derivation of clinical grade hESCs in the future
(14). The Yazd3 hESC line was derived from a
zona-free embryo following the thawing process.
While the ICM is known to be the usual source
for hESC derivation, the development of hESCs
from single blastomeres of cleavage- and morula-
stage embryos (12, 40, 41, 42) has also been
reported, but these methods have not been used
routinely.
To avoid animal contamination following the co-
culture of hESCs with MEFs, xeno-free derivation
of hESC lines can be achieved by using human
feeders including HFFs (18), HFGFs (13), human
endometrial-derived fibroblasts (19), hESC-derived
feeder (EDF), and human placental fibroblast feed-
ers (43). In this regard, hESCs derived fibroblast-like
cells conditionedmedium demonstrated to support
undifferentiated hESC proliferation under feeder-
free conditions (44).
Herein, MEFs were used for the initial derivation
of Yazd1-3 hESC lines, followed by expansion of
the cell lines on MEFs and YhFFs#8. Mesenchymal
stem/stromal cells have been derived from Yazd
hESC lines (27), although hESC-derived MSCs have
yet to be used as feeders.
The Yazd cell lines, which were characterized
as described above and have been used during
workshops (45), are available for other research
groups and companies to use, according to Yazd
Reproductive Sciences Institute rules and laws, as
the owner of the cell lines.
5. Conclusion
NewhESC lines (Yazd1-3) were derived onmicro-
drops of an MEF feeder layer, without immuno-
surgery, using whole blastocyst culture. Following
expansion of the cell lines, YhFFs#8 were used as
a xeno-free condition with KOSR/HES. This study is
the first report of Cryotech and Cryowin tools being
used for the vitrification of hESCs in the very early
stages of derivation. Further studies are in progress
to evaluate the efficiency of this method compared
with other techniques and tools.
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